CX3CL1 and Parkinson disease: Increased CX3CL1 signaling decreases neuronal loss from α‐synuclein exposure by modulating microglia to a more neuroprotective and less proinflammatory phenotype, and loss of CX3CR1 on microglia leads to an increase in PD pathology.